Category: Pharmaceutical company
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 864.19M Prev closed: Open: 15.61 High: 15.89 Low: 15.03 52 week low: 15.03 52 week high: 73.02 Dividends: No Dividends Next ER: November 9, 2022
About the Company Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPRâCas9 gene editing technology. The company went public on 2 Feb 2016.
Earnings History Date EPS / Forecast Revenue / Forecast March 7, 2023 November 2, 2022 -0.81 / -0.8642K / 4.71MBeat! August 3, 2022 -0.78 / -0.80836.4M / 4.29MBeat! May 4, 2022 -0.74 / -0.78176.77M / 3.85MBeat! February 24, 2022 -0.61 / -0.712212.47M / 4.64MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 17.34 18.35 18.35
16.92
1.94M -6.07% Aug 15, 2022 18.46 18.59 18.88
17.90
1.47M -1.65% Aug 12, 2022 18.77 18.41 19.03
17.83
1.49M 3.76% Aug 11, 2022 18.09 18.88 19.50
17.92
1.82M -2.48% Aug 10, 2022 18.55 18.90 18.94
18.10
1.70M 3.11% Aug 9, 2022 17.99 18.61 18.75
17.15
1.99M -5.96% Aug 8, 2022 19.13 19.53 19.97
18.73
1.34M -1.49% Aug 5, 2022 19.42 18.51 19.43
18.00
1.51M 1.41% Aug 4, 2022 19.15 18.53 19.19
18.05
1.85M 2.46% Aug 3, 2022 18.69 17.54 19.40
17.49
3.09M 13.41% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Citing Small Population, Editas Medicine Pauses Work On Gene Therapy Trial For Genetic Eye Disorder finance.yahoo.com Nov 21, 2022 1:01 pm
Editas' (EDIT) Q1 Loss Narrows, Revenues Beat Estimates finance.yahoo.com Nov 21, 2022 11:54 am
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents finance.yahoo.com Nov 21, 2022 11:26 am
Editas' (EDIT) EDIT-301 Gets Orphan Drug Tag for Beta Thalassemia finance.yahoo.com Nov 21, 2022 10:30 am
Down 35% This Year, Is This Small-Cap Stock a Buy? fool.com Nov 21, 2022 10:30 am
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week fool.com Nov 21, 2022 10:01 am
Editas (EDIT) Pauses Eye Disease Study on EDIT-101, Stock Down finance.yahoo.com Nov 21, 2022 9:51 am
Editas Medicine Appoints Gilmore ONeill as Chief Executive Officer finance.yahoo.com Nov 21, 2022 7:30 am
Editas Medicine Announces First Quarter 2022 Results and Business Updates finance.yahoo.com Nov 21, 2022 6:45 am
Editas Medicine Announces Third Quarter 2022 Results and Business Updates finance.yahoo.com Nov 21, 2022 6:30 am
Editas Medicine (NASDAQ:EDIT) adds US$129m to market cap in the past 7 days, though investors from a year ago are still down 61% finance.yahoo.com Nov 21, 2022 4:15 am
Where Will Editas Medicine Be in 1 Year? fool.com Nov 20, 2022 8:30 am
10 Most Promising Gene Therapy Companies to Watch finance.yahoo.com Nov 14, 2022 2:31 pm
Editas' (EDIT) Q3 Earnings Beat Estimates, Pipeline in Focus finance.yahoo.com Nov 3, 2022 1:11 pm
10 Best Gene Editing Stocks To Buy finance.yahoo.com Oct 14, 2022 9:49 am
Investors one-year losses grow to 78% as the stock sheds US$94m this past week finance.yahoo.com Sep 1, 2022 9:02 am
Editas (EDIT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? finance.yahoo.com Aug 19, 2022 9:55 am
Is Editas Medicine (NASDAQ:EDIT) Using Debt In A Risky Way? finance.yahoo.com Aug 5, 2022 7:24 am
Why Editas Medicine Was Winning on Wednesday fool.com Aug 3, 2022 4:41 pm
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com Jun 14, 2022 7:55 am This company doesn't provide a dividend.
Key Persons Talk about Editas below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 33 HOLD 42 SELL 25
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet